Anika Therapeutics reported disappointing financial results for the first quarter of 2025, missing both earnings and revenue forecasts. The company posted an earnings per share (EPS) of -$0.06, ...
Shares of Anika Therapeutics fell during Friday's trading after the company said sales fell in one of its segments and lowered full-year guidance for that unit. Shares slipped 19.3% to $11.89 and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results